¹û¶³´«Ã½

As the risk-free rate shifts, the uses – and limits – of the Sharpe ratio come into relief

Should investors include CEO fecundity in their due diligence?

It’s a tough call, but it looks like investors have underestimated Centrica

Is wide analyst disagreement a reliably bearish signal for equities?

This year, going short has been the only reliable strategy in our ideas section

Should you 'swallow' financial pain, or try to process it?

Hunting for parallels to (and possible ideas in) a battered and bruised stock market

Quant signals are pointing toward old-economy stocks. But these stocks' cheapness tells us something else

Can 2029 forecasts help uncover value in 2022?

Chart toppers vs market toppiness